Physician profile
Marcus MD Ford
NPI 1790075323
$296,030.66
in general payments reported to CMS, 2019-2025
11 companies · $112K in 2025
The $112K reported for 2025 was more than what 93% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,345 · 2020: $5,329 · 2021: $28K · 2022: $27K · 2023: $36K · 2024: $83K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $206K · Travel and Lodging: $20K · Food and Beverage: $5,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $206,300.00 |
| Travel and Lodging | $19,660.73 |
| Food and Beverage | $5,033.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $197,666.69 | 2021-2025 | Gmk Sphere, Amistem, Spherika |
| Zimmer Biomet Holdings, INC. | $38,354.13 | 2023-2025 | Rosa, Persona, Comprehensive Shoulder System |
| Medical Device Business Services, INC. | $29,379.38 | 2019-2022 | |
| Osteoremedies, LLC | $12,273.09 | 2019-2024 | Osteoboost Select 10cc, Osteoboost Select 10cc, Remedy Spectrum Gv Spacer |
| Microport Orthopedics INC | $6,477.87 | 2020-2022 | |
| Depuy Synthes Products, INC. | $6,004.29 | 2021 | |
| Smith+Nephew, INC. | $3,898.44 | 2019-2025 | Pico 7 |
| Depuy Synthes Sales INC. | $1,853.92 | 2019-2025 | Attune |
| Stryker Corporation | $61.00 | 2024-2025 | Tritanium |
| Avanos Medical | $40.59 | 2024 | Grpro 2.1 |
| Kerecis Limited | $21.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.